Literature DB >> 18056458

Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.

Jingsong Li1, Jing Tan, Li Zhuang, Birendranath Banerjee, Xiaojing Yang, Jenny Fung Ling Chau, Puay Leng Lee, Manoor Prakash Hande, Baojie Li, Qiang Yu.   

Abstract

Activation of the p53 tumor suppressor upon DNA damage elicits either cell cycle arrest or apoptosis, and the precise mechanism governing cell fate after p53 response has not been well defined. Through genomic analysis, we have identified the ribosomal protein S27-like (RPS27L) as a novel p53 transcriptional target gene. Although RPS27L mRNA levels were consistently induced after diverse p53 activating signals, its change in protein level was stimuli-dependent: it was up-regulated when cells were arrested in response to DNA-damaging agents Adriamycin or VP16 but was down-regulated when cells underwent apoptosis in response to antimetabolite agent 5-fluorouracil. RPS27L is a nuclear protein that forms nuclear foci upon DNA damage. Depletion of RPS27L resulted in deficiency in DNA damage checkpoints, leading to conversion of DNA damage-induced p53 response from cell cycle arrest to apoptosis. We further show that RPS27L positively regulates p21 protein expression. Through this mechanism, RPS27L induction by p53 facilitates p21-mediated cell cycle arrest and protects against DNA damage-induced apoptosis. Thus, RPS27L modulates DNA damage response and functions as a part of the control switch to determine cell fate to DNA damage-p53 response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056458     DOI: 10.1158/0008-5472.CAN-07-1088

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.

Authors:  Elaine M Sloand; Matthew J Olnes; Aarthie Shenoy; Barbara Weinstein; Carol Boss; Kelsey Loeliger; Colin O Wu; Kenneth More; A John Barrett; Phillip Scheinberg; Neal S Young
Journal:  J Clin Oncol       Date:  2010-11-01       Impact factor: 44.544

Review 2.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

3.  The DEAD-box RNA helicase DDX41 is a novel repressor of p21WAF1/CIP1 mRNA translation.

Authors:  Dominik Peters; Claudia Radine; Alina Reese; Wilfried Budach; Dennis Sohn; Reiner U Jänicke
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

4.  Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells.

Authors:  Pingping Mao; Mary P Hever; Lynne M Niemaszyk; Jessica M Haghkerdar; Esty G Yanco; Damayanti Desai; Maroun J Beyrouthy; Joanna S Kerley-Hamilton; Sarah J Freemantle; Michael J Spinella
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

5.  Functional Genomics of the Pediatric Obese Asthma Phenotype Reveal Enrichment of Rho-GTPase Pathways.

Authors:  Deepa Rastogi; Andrew D Johnston; John Nico; Lip Nam Loh; Yurydia Jorge; Masako Suzuki; Fernando Macian; John M Greally
Journal:  Am J Respir Crit Care Med       Date:  2020-07-15       Impact factor: 21.405

6.  Proposed megakaryocytic regulon of p53: the genes engaged to control cell cycle and apoptosis during megakaryocytic differentiation.

Authors:  Pani A Apostolidis; Stephan Lindsey; William M Miller; Eleftherios T Papoutsakis
Journal:  Physiol Genomics       Date:  2012-05-01       Impact factor: 3.107

7.  Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway.

Authors:  Susana Llanos; Manuel Serrano
Journal:  Cell Cycle       Date:  2010-10-09       Impact factor: 4.534

8.  Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage.

Authors:  Z Wu; S T Lee; Y Qiao; Z Li; P L Lee; Y J Lee; X Jiang; J Tan; M Aau; C Z H Lim; Q Yu
Journal:  Cell Death Differ       Date:  2011-05-06       Impact factor: 15.828

9.  The Many Faces of MDM2 Binding Partners.

Authors:  Maurisa F Riley; Guillermina Lozano
Journal:  Genes Cancer       Date:  2012-03

10.  Dissection of a complex transcriptional response using genome-wide transcriptional modelling.

Authors:  Martino Barenco; Daniel Brewer; Efterpi Papouli; Daniela Tomescu; Robin Callard; Jaroslav Stark; Michael Hubank
Journal:  Mol Syst Biol       Date:  2009-11-17       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.